Frank Pasqualone, Director at Enveric Biosciences, Inc. (ENVB), bought 1,000 shares at $2.14 ($2K) on 2023-09-15, disclosed to the SEC on 2023-09-19.
Open-market purchase of $2k ENVB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.